Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms TD-033 |
Target |
Mechanism CRBN inhibitors(Cereblon inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC42H49N7O9S |
InChIKeyZBCXOELGHROVDK-FOLICCEFSA-N |
CAS Registry- |